Gene-Editing Therapy Shows Promise in Hereditary Angioedema

(MedPage Today) -- A single dose of the CRISPR-based gene-editing therapy NTLA-2002 significantly reduced angioedema attacks compared with placebo in patients with hereditary angioedema, according to results from a phase II randomized study presented...